Zytiga is used for the treatment of newly diagnosed, advanced prostate cancer patients
News
CMA imposes substantial fines on pharma firms for overcharging the NHS
Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets
Spaces still available in the 2021 Sales Awards
There are still available spaces in the 2021 Sales Awards as we enter the last couple of months for entries.
Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status
At the same time, Affinivax and Astellas revealed positive results from the Phase II trial of ASP3772
Galapagos reports early clinical results for SIK inhibitor
Novel drug candidate found to be generally safe and well-tolerated in inflammatory indications
Cancer Research UK reports ‘most successful financial year’ for its spinouts
Investment raised by its spinouts more than doubled in the last year, the charity has reported
Merck’s MET inhibitor tepotinib gains positive opinion from MHRA
The positive opinion has been issued via the MHRA’s early access the medicine (EAMS) scheme
NICE to develop guideline for rare blood clots associated with COVID-19 vaccination
Condition is ‘extremely’ rare, with only 14.2 cases occurring per million doses of the COVID-19 vaccine
NHS invests £20m to fast-track measures for quick cancer diagnosis
Funding will go towards a number of measures aimed at speeding up cancer diagnosis and treatment
Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients
The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study
AZ scores final clearance for Alexion acquisition in the UK
UK approval of the acquisition comes just a week after the merger scored clearance in the EU
Quidel gains CE mark for combined COVID-19, flu and RSV diagnostic test
Company’s molecular testing platform and first assay panel can now be marketed in the EU
Aetion and Cegedim expand real-world data partnership
In 2020, the two partners announced an initial collaboration to integrate Cegedim’s ‘THIN’ European real-world data into Aetion’s evidence platform
Tecentriq, Kesimpta lead latest SMC decisions
SMC was unable to accept Pfizer’s Vyndaqel for use in patients with transthyretin amyloidosis
New hope for long COVID blood tests after antibody discovery
Researchers discover presence of ‘autoantibodies’ in people with persistent COVID-19 symptoms
